Battle brewing over ‘Pharma Bro’ Martin Shkreli’s controlling stake in Phoenixus

Martin Shkreli may be losing his grip on the drug company he controls from prison.

Three days after the “Pharma Bro” bested a group of shareholders who tried to seize control of his company Phoenixus by ousting his cronies from the board, more efforts were made to relieve him of his controlling 44-percent stake in the pharmaceutical company, which he used to win the proxy battle. On Thursday, a man owed millions by Shkreli, asked a Manhattan federal judge to delay no further in appointing a receiver to liquidate Shkreli’s Phoenixus stake.